Quick answer: In head-to-head trials, tirzepatide (a dual GLP-1/GIP receptor agonist) produced greater weight loss than semaglutide (a single GLP-1 agonist) 20.2% vs 13.7% over 72 weeks in SURMOUNT-5 though semaglutides single-pathway selectivity keeps it valuable in research
Our team of allergists would love to help you with a treatment plan so you can enjoy the spring as intended
Comorbidities: Documentation of weight-related health conditions (high blood pressure, high cholesterol, sleep apnea, cardiovascular disease) that support the need for additional treatment
Why is it not working for me? Race to Erase MS 31st Annual Gala Arrivals Ashley Benson clapped back at Instagram commenters who speculated she took Ozempic to lose weight after giving birth to her daughter in February 2024
Effectiveness In the main clinical study behind the pill (the 64-week OASIS 4 trial in adults with obesity or overweight), participants taking the 25 mg dose alongside diet and exercise lost on average around 14% of their starting body weight, compared with roughly 2.4% for those on a placebo